Aska Pharmaceutical Holdings Co. Ltd. (4886)
Market Closed
10 Aug, 06:00
JPX JPX Primary ¥
2,035. 00
+25
+1.2438%
¥
58.35B Market Cap
- P/E Ratio
66% Div Yield
125,800 Volume
- Eps
¥ 2,010
Previous Close Want to track 4886 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aska Pharmaceutical Holdings Co. Ltd. (4886) Statistics
Valuation metrics
Market Cap 58.35B
Enterprise value 58.38B
Trailing P/E (ttm) 10.52
Forward P/E 16.72
PEG ratio 1.7
Price/Sales (ttm) 0.8
Price/Book (mrq) 0.82
Enterprise Value/Revenue 0.82
Enterprise Value/EBITDA 6.55
Overview
Shares outstanding 28.4M
Float 20.05M
Shares short -
% Held by insiders 0.27%
% Held by institutions 0.34%
Average volume (10 days) 155.84K
Average volume (90 days) 97.17K
Price summary
52-Week low 1,917
52-Week high 3,045
Beta 0.4
50-Day moving average 2,233.8
200-Day moving average 2,463.77
Dividends and splits
Forward annual dividend rate 66
Forward annual dividend yield 0.0233%
Trailing annual dividend rate 60
Trailing annual dividend yield 0.0299%
5-Year annual dividend yield -
Payout ratio 0.31
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.08%
Operating margin 0.08%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.08%
Income Statement
Revenue (ttm) 71.13B
Revenue per share (ttm) 2,505.09
Quarterly revenue growth (yoy) 0.17%
Gross profit (ttm) 34.14B
EBITDA 8.92B
Net income to common (ttm) 5.42B
Diluted EPS (ttm) 191.07
Quarterly earnings growth (yoy) 0.52%
Balance Sheet
Total cash (mrq) 11.02B
Total cash per share (mrq) 388.09
Total debt (mrq) 11.43B
Total Debt/Equity (mrq) 0.16
Current ratio (mrq) 2.76%
Book value per share (mrq) 2,692.67
Cash Flow
Cash flow statement 6.3B
Levered free cash flow (LFCF) 806.5M
